ArticleLife (Basel, Switzerland)2025

A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs.

Valeria Bettinsoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.